Clinical Trials Logo

Phobic Disorders clinical trials

View clinical trials related to Phobic Disorders.

Filter by:

NCT ID: NCT01687764 Recruiting - Clinical trials for Generalized Anxiety Disorder

Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children

Start date: August 2011
Phase: N/A
Study type: Interventional

The objective of this project is to test the combination of active or placebo Attentional Bias Modification Treatment (ABMT) to either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for anxiety disorders in children.

NCT ID: NCT01654510 Completed - Clinical trials for Social Anxiety Disorder

A Systems Level Intervention for Unemployed Persons With Social Anxiety Disorder

Start date: April 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of the proposed research is to design and develop a culturally appropriate, vocationally focused, sustainable, cognitive-behavioral intervention for unemployed, economically disadvantaged, urban-dwelling persons whose job attainment efforts have been undermined by the presence of social anxiety disorder.

NCT ID: NCT01623583 Terminated - Phobic Disorders Clinical Trials

Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias

Start date: April 2014
Phase: Phase 4
Study type: Interventional

An arteriovenous fistula or graft access (AVF/AVG) for dialysis is often considered a superior option for delivery of dialysis, but requires needles to be inserted. Patients on dialysis who indicate fear of needles as the reason for not switching from a long-term central venous catheter (CVC) access to a fistula or graft access and who otherwise meet the eligibility criterial will be asked to participate. Patients will receive either a standard or an enhanced intervention to address their fear of needles. The enhanced intervention includes the standard intervention plus video training about Synera and trying out an actual patch. Over the 4 months following the intervention, how many patients sign up to switch access will be tracked.

NCT ID: NCT01577303 Completed - Social Phobia Clinical Trials

Treatment of Social Phobia With Cognitive Bias Modification

Start date: April 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether different internet-based treatment programs, consisting of cognitive bias modification, reduce symptoms of social phobia among a population diagnosed with this disorder.

NCT ID: NCT01574014 Terminated - Phobic Disorders Clinical Trials

Glucocorticoid Treatment for Social Phobia

Start date: July 2009
Phase: Phase 2
Study type: Interventional

Social phobia is the third most common psychiatric disorder besides depression and alcoholism. Several studies have demonstrated the efficacy of cognitive-behavioral therapy in the treatment of social phobia. Nevertheless, there is no effect in a third of the people at the existing treatment methods. Pharmacological therapies have similar effects, but there is a high rate of relapse after discontinuation of medication. Social phobia is characterized by fear of performance or interaction situations. The strong fear of negative evaluation by others is usually accompanied by a marked avoidance behavior and increased physical symptoms such as blushing, sweating, palpitations, or tremors. The confrontation with a phobic stimulus leads to a retrieval of stimulus-associated aversive memories, resulting in an immediate anxiety response. Several studies had already shown that elevated glucocorticoids impair retrieval of declarative memory contents in healthy subjects. The investigators demonstrated an anxiety-reducing effect after the administration of cortisone before the confrontation with a phobic stimulus in patients with social and spider phobia.

NCT ID: NCT01570400 Completed - Social Phobia Clinical Trials

Treatment of Social Phobia With Combined Cognitive Bias Modification and iCBT

SOFIE13a
Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether an internet-based treatment program, consisting of combined cognitive bias modification and cognitive behavioral therapy, reduces symptoms of social phobia among a population diagnosed with this disorder.

NCT ID: NCT01563198 Completed - Claustrophobia Clinical Trials

Reduction of Claustrophobia and Patient Motion After Training of MRI Personnel in Comfort TalkTM

Start date: August 2011
Phase: N/A
Study type: Interventional

Annually, an estimated 700,000 patients do not complete their scheduled MRI scans because of claustrophobia or inability to hold still. Training staff working in MRI facilities to provide Comfort Talk® promises to enable patients to complete and obtain high quality imaging without medication, which will increase comfort and reduce sedation risks for the patients, and increase efficiency and reduce loss of revenue for the facilities.

NCT ID: NCT01557894 Completed - Phobia, Social Clinical Trials

Internet Treatment for Social Phobia in Romania

iSOFIE-Ro
Start date: April 2012
Phase: N/A
Study type: Interventional

The main aim of this study is to investigate the effectiveness of an Internet-delivered intervention for social phobia by comparing it to a waitlist control group. The second aim of the study is to track the potential changes in participants' thinking patterns. Because this is among the first guided Internet-delivered interventions conducted in Romania, the treatment credibility will also be investigated. Finally, the predictive power of anxiety sensitivity for both SAD symptoms and the treatment effectiveness will be investigated.

NCT ID: NCT01470469 Completed - Anxiety, Separation Clinical Trials

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

Start date: January 4, 2012
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and tolerability of SPD503 in subjects aged 6-17 years with GAD, SAD, or SoP based on treatment emergent adverse events (TEAEs), vital signs and ECGs.

NCT ID: NCT01463137 Completed - Social Phobia Clinical Trials

Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder

SOFIE-11
Start date: October 2011
Phase: N/A
Study type: Interventional

A study investigating six different versions of a computerized attention bias modification internet program in the treatment of social phobia / social anxiety disorder.